France-based medical device company Gradient Denervation Technologies has secured €14m ($15m) in a Series A funding round to advance the clinical development of its ultrasound-based catheter device.
The financing round was led by venture capital company Asabys Partners through its new fund, Sabadell Asabys II, with Thuja Capital and founding investor Sofinnova Partners taking part.
Gradient also plans to use the investment to progress the assessment of its catheter to treat pulmonary hypertension.
